SG11202009257TA - Pharmaceutical compositions for inhibiting inflammatory cytokines - Google Patents
Pharmaceutical compositions for inhibiting inflammatory cytokinesInfo
- Publication number
- SG11202009257TA SG11202009257TA SG11202009257TA SG11202009257TA SG11202009257TA SG 11202009257T A SG11202009257T A SG 11202009257TA SG 11202009257T A SG11202009257T A SG 11202009257TA SG 11202009257T A SG11202009257T A SG 11202009257TA SG 11202009257T A SG11202009257T A SG 11202009257TA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical compositions
- inflammatory cytokines
- inhibiting inflammatory
- inhibiting
- cytokines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649940P | 2018-03-29 | 2018-03-29 | |
| PCT/IL2019/050359 WO2019186561A1 (en) | 2018-03-29 | 2019-03-28 | Pharmaceutical compositions for inhibiting inflammatory cytokines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009257TA true SG11202009257TA (en) | 2020-10-29 |
Family
ID=68058011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009257TA SG11202009257TA (en) | 2018-03-29 | 2019-03-28 | Pharmaceutical compositions for inhibiting inflammatory cytokines |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11419913B2 (en) |
| EP (1) | EP3773661A4 (en) |
| JP (2) | JP7421219B2 (en) |
| KR (1) | KR20200138326A (en) |
| CN (1) | CN112203674A (en) |
| AU (1) | AU2019245521A1 (en) |
| BR (1) | BR112020019347A2 (en) |
| CA (1) | CA3094295A1 (en) |
| IL (1) | IL277436A (en) |
| MX (1) | MX2020009999A (en) |
| PH (1) | PH12020551573A1 (en) |
| SG (1) | SG11202009257TA (en) |
| UA (1) | UA126941C2 (en) |
| WO (1) | WO2019186561A1 (en) |
| ZA (1) | ZA202006412B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4034147A4 (en) * | 2019-09-26 | 2023-10-18 | S.I.S. Shulov Innovative Science Ltd. | Compositions and methods for treating degenerative, age-related and trauma-induced disorders |
| CA3155594A1 (en) * | 2019-09-26 | 2021-04-01 | S.I.S. Shulov Innovative Science Ltd. | Topical anti-aging compositions comprising a tetrapeptide |
| US20230128280A1 (en) | 2020-10-23 | 2023-04-27 | Lg Energy Solution, Ltd. | Electrode Insulation Liquid Supply Apparatus and Electrode Insulation Liquid Supply Method |
| BR112023025144A2 (en) * | 2021-05-31 | 2024-02-27 | S I S Shulov Innovative Science Ltd | PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT OR PREVENTION OF RESPIRATORY DISCOMFORT, AND, METHOD OF TREATMENT OF A SUBJECT INFECTED WITH CORONAVIRUS |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1172391B (en) | 1983-12-23 | 1987-06-18 | Polifarma Spa | TYRPEPTID COMPOUNDS CONTAINING PYROGLUTAMINIC ACID AND TRIPTOPHAN, PRODUCTION PROCEDURE AND THERAPEUTIC APPLICATIONS |
| US6090790A (en) | 1989-12-14 | 2000-07-18 | Eriksson; Elof | Gene delivery by microneedle injection |
| AR026801A1 (en) | 2000-01-12 | 2003-02-26 | Medidom Lab | SUBSTANCES FOR USE IN THE TREATMENT OF PSORIASIS |
| IL137820A (en) | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
| MX2010010334A (en) | 2008-03-24 | 2010-10-08 | Celgene Corp | Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide. |
| WO2010032322A1 (en) | 2008-09-22 | 2010-03-25 | 日清ファルマ株式会社 | Antiinflammatory peptide |
| KR101290745B1 (en) * | 2010-06-03 | 2013-07-29 | 한국해양과학기술원 | Pharmaceutical Composition for Prevention or Treatment of Inflammatory or Allergy Diseases Comprising Ramalin |
| CA2830135C (en) * | 2011-03-28 | 2019-12-17 | S.I.S. Shulov Innovative Science Ltd. | Method for treating disorders of the skin |
| WO2015197194A2 (en) * | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| CN103724204B (en) | 2013-11-27 | 2016-05-11 | 北京化工大学 | A kind of water soluble starter and preparation |
| EP3160989A2 (en) * | 2014-06-26 | 2017-05-03 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
-
2019
- 2019-03-28 AU AU2019245521A patent/AU2019245521A1/en active Pending
- 2019-03-28 UA UAA202006701A patent/UA126941C2/en unknown
- 2019-03-28 EP EP19777428.4A patent/EP3773661A4/en active Pending
- 2019-03-28 MX MX2020009999A patent/MX2020009999A/en unknown
- 2019-03-28 WO PCT/IL2019/050359 patent/WO2019186561A1/en active Application Filing
- 2019-03-28 CA CA3094295A patent/CA3094295A1/en active Pending
- 2019-03-28 CN CN201980031430.0A patent/CN112203674A/en active Pending
- 2019-03-28 KR KR1020207031019A patent/KR20200138326A/en not_active Application Discontinuation
- 2019-03-28 US US17/041,051 patent/US11419913B2/en active Active
- 2019-03-28 JP JP2020552781A patent/JP7421219B2/en active Active
- 2019-03-28 BR BR112020019347-0A patent/BR112020019347A2/en unknown
- 2019-03-28 SG SG11202009257TA patent/SG11202009257TA/en unknown
-
2020
- 2020-09-17 IL IL277436A patent/IL277436A/en unknown
- 2020-09-28 PH PH12020551573A patent/PH12020551573A1/en unknown
- 2020-10-15 ZA ZA2020/06412A patent/ZA202006412B/en unknown
-
2022
- 2022-08-08 US US17/818,118 patent/US20220387547A1/en active Pending
-
2023
- 2023-11-29 JP JP2023201678A patent/JP2024015099A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL277436A (en) | 2020-11-30 |
| RU2020134114A (en) | 2022-04-29 |
| EP3773661A4 (en) | 2021-12-08 |
| ZA202006412B (en) | 2023-03-29 |
| AU2019245521A1 (en) | 2020-11-12 |
| CA3094295A1 (en) | 2019-10-03 |
| US20210138023A1 (en) | 2021-05-13 |
| MX2020009999A (en) | 2020-11-06 |
| CN112203674A (en) | 2021-01-08 |
| BR112020019347A2 (en) | 2021-02-17 |
| WO2019186561A1 (en) | 2019-10-03 |
| KR20200138326A (en) | 2020-12-09 |
| US11419913B2 (en) | 2022-08-23 |
| PH12020551573A1 (en) | 2021-09-13 |
| JP2024015099A (en) | 2024-02-01 |
| JP2021519773A (en) | 2021-08-12 |
| UA126941C2 (en) | 2023-02-22 |
| EP3773661A1 (en) | 2021-02-17 |
| JP7421219B2 (en) | 2024-01-24 |
| US20220387547A1 (en) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280540A (en) | Solid self-emulsifying pharmaceutical compositions | |
| IL283179A (en) | Fusosome compositions for cns delivery | |
| IL279442A (en) | Pharmaceutical compositions comprising meloxicam | |
| GB201811312D0 (en) | Compositions | |
| GB2586745B (en) | Compositions | |
| ZA202006412B (en) | Pharmaceutical compositions for inhibiting inflammatory cytokines | |
| SG11202009259VA (en) | Compositions | |
| SG11202104306XA (en) | Compositions | |
| GB201804548D0 (en) | Pharmaceutical compositions | |
| GB201807053D0 (en) | Pharmaceutical composition | |
| GB201803923D0 (en) | Compositions | |
| SG11202103374TA (en) | Pharmaceutical composition | |
| GB201808571D0 (en) | Pharmaceutical compositions | |
| EP4081251A4 (en) | Pharmaceutical compositions | |
| FI3908321T3 (en) | Pharmaceutical composition | |
| GB201808567D0 (en) | Pharmaceutical compositions | |
| GB2570649B (en) | Compositions | |
| GB201805676D0 (en) | Compositions | |
| GB201810109D0 (en) | Pharmaceutical compositions | |
| GB201810261D0 (en) | New pharmaceutical compositions | |
| GB201810265D0 (en) | New pharmaceutical compositions | |
| GB201904785D0 (en) | New pharmaceutical compositions | |
| GB201904783D0 (en) | New pharmaceutical compositions | |
| GB201904771D0 (en) | New pharmaceutical compositions | |
| GB201904767D0 (en) | New pharmaceutical compositions |